CIK 0000893949
- Large accelerated filer
Pediatrix Medical Group, Inc.
Sign in to watch- Ticker
- MD
- Exchange
- NYSE
- Industry
- Services-Hospitals
- FY end
- Dec 31
- Incorporated
- FL
- Entity type
- Operating
- EIN
- 263667538
- Phone
- +1 954-384-0175
- Business address
- 1301 CONCORD TERRACE, SUNRISE, FL, 33323
- Former names
- MEDNAX, INC., PEDIATRIX MEDICAL GROUP INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-05-05 | Kadre Manuel Director | Purchase | +21,704 | $55.79 | $1.2M | 111,255 |
| 2017-03-15 | Andreano Dominic J SVP, General Counsel and Secy | Sale | −6,517 | $70.84 | $462K | 18,229.22 |
| 2017-02-23 | SOSA ENRIQUE Director | Option exercise | +10,668 | $32.33 | $345K | 21,923 |
| 2017-02-23 | SOSA ENRIQUE Director | Sale | −10,668 | $69.65 | $743K | 11,255 |
| 2017-02-23 | SOSA ENRIQUE Director | Option exercise · Stock Options (Right to Buy) | −10,668 | $32.33 | $345K | 0 |
| 2017-02-17 | Lopez-Blanco Vivian Chief Financial Officer | Sale | −15,164 | $70.01 | $1.1M | 59,097.24 |
| 2017-02-16 | Pepia John C Principal Accounting Officer | Option exercise | +2,500 | $28.55 | $71K | 31,025 |
| 2017-02-16 | Pepia John C Principal Accounting Officer | Sale | −1,000 | $69.58 | $70K | 30,025 |
| 2017-02-16 | Pepia John C Principal Accounting Officer | Sale | −1,500 | $69.58 | $104K | 28,525 |
| 2017-02-16 | Pepia John C Principal Accounting Officer | Option exercise · Stock Options (Right to Buy) | −2,500 | $28.55 | $71K | 0 |
| 2017-02-16 | GABOS PAUL G Director | Option exercise | +10,668 | $32.33 | $345K | 21,923 |
| 2017-02-16 | GABOS PAUL G Director | Option exercise | +10,668 | $27.72 | $296K | 32,591 |
| 2017-02-16 | GABOS PAUL G Director | Sale | −21,336 | $69.63 | $1.5M | 11,255 |
| 2017-02-16 | GABOS PAUL G Director | Option exercise · Stock Options (Right to Buy) | −10,668 | $32.33 | $345K | 0 |
| 2017-02-16 | GABOS PAUL G Director | Option exercise · Stock Options (Right to Buy) | −10,668 | $27.72 | $296K | 0 |
| 2017-02-16 | Andreano Dominic J SVP, General Counsel and Secy | Option exercise | +6,000 | $28.55 | $171K | 30,746.22 |
| 2017-02-16 | Andreano Dominic J SVP, General Counsel and Secy | Sale | −6,000 | $69.59 | $418K | 24,746.22 |
| 2017-02-16 | Andreano Dominic J SVP, General Counsel and Secy | Option exercise · Stock Options (Right to Buy) | −6,000 | $28.55 | $171K | 0 |
| 2017-02-13 | MEDEL ROGER MD Chief Executive Officer | Gift | −16,020 | 1,233,304 | ||
| 2017-02-10 | Goldschmidt, MD Pascal J Director | Other disposition | −25,294 | $67.82 | $1.7M | 17,749 |
Page 19 of 22 · 431 trades